Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

J L Nam,R J Wakefield,R Reece,A W Morgan,M Quinn,D M Van Der Heijde,E M A Hensor,M H Buch,H I Keen,E Villeneuve,P G Conaghan,A M Keenan,P S Helliwell,P Emery,A K Gough,M J Green

doi:10.1136/annrheumdis-2013-203440

Remission induction comparing infliximab and high-dose intravenous steroid, followed by treat-to-target: a double-blind, randomised, controlled trial in new-onset, treatment-naive, rheumatoid arthritis (the IDEA study)

J L Nam, R J Wakefield + Show 14 more

https://doi.org/10.1136/annrheumdis-2013-203440

Copy DOI

Journal: Annals of the Rheumatic Diseases	Publication Date: Aug 2, 2013
Citations: 140

Affiliation: NIHR Leeds Musculoskeletal Biomedical Research Unit, University of Leeds, York Hospital

#Infliximab Group #Total Sharp-van Der Heijde Score + Show 8 more

Abstract
Full-Text PDF
Similar Papers

Abstract

ObjectivesIn disease modifying antirheumatic drug (DMARD)-naive early rheumatoid arthritis (RA), to compare the efficacy of methotrexate (MTX) and infliximab (IFX) with MTX and intravenous corticosteroid for remission induction.MethodsIn a 78-week...

Full Text